Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication

Rheumatology (Oxford). 2007 Feb;46(2):367-8. doi: 10.1093/rheumatology/kel389. Epub 2006 Dec 13.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antiviral Agents / therapeutic use
  • Cryoglobulinemia / virology*
  • Follow-Up Studies
  • Hepatitis C, Chronic / complications*
  • Humans
  • Male
  • Syndrome

Substances

  • Antiviral Agents